Prothena Corporation PLC (NASDAQ:PRTA)

24.62
Delayed Data
As of May 07
 +0.96 / +4.06%
Today’s Change
9.25
Today|||52-Week Range
28.66
+105.00%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.1B

Company Description

Prothena Corp. Plc is a clinical-stage neuroscience company. It focuses on the discovery and development of novel therapies to change the course of devastating diseases. The firm's clinical pipeline includes both wholly-owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland.

Contact Information

Prothena Corp. Plc
77 Sir John Rogersons Quay
Dun Laoghaire Dublin 2
P:(531) 236-2500
Investor Relations:
(650) 837-8535

Employees

Shareholders

Other institutional48.85%
Mutual fund holders34.23%
Individual stakeholders32.38%

Top Executives

Gene G. KinneyPresident, Chief Executive Officer & Director
Tran B. NguyenChief Operating & Financial Officer
Wagner M. ZagoChief Scientific Officer
Hideki GarrenChief Medical Officer
Radhika TripuraneniChief Development Officer